ArticleHeart (British Cardiac Society)2026
Congenital heart disease in England: a national cohort study from fetal diagnosis to end of infancy.
Article in Heart (British Cardiac Society), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Registry data on congenital heart disease trajectories from fetal life through infancy empower patients, relatives and healthcare professionals and expose blind angles.Heart (British Cardiac Society) · 2026Article
- The Road to Hell Winds On: The High Administrative Burden of Maintaining Linked National Health Data.International journal of population data science · 2026Article
Corrections and comments
- Comment on
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPopulation studies of congenital heart disease (CHD) often include only children receiving cardiac interventions, underestimating the burden of cases without intervention. We evaluated outcomes for all detected structural CHD cases in England from fetal life to the age of 1 year.
methodWe linked the National Congenital Anomaly and Rare Disease Registration Service, the National Congenital Heart Disease Audit, and Office for National Statistics mortality records to construct an incident cohort with estimated delivery/birth dates 2018-2020. Outcomes were: termination of pregnancy, fetal loss (miscarriage/stillbirth), live birth with no cardiac intervention in infancy, and live birth with intervention(s) in infancy. Infant mortality at the age of 1 year was assessed.
resultsAmong 11 265 CHD cases, 63.7% were antenatally detected (95% CI 62.8% to 64.6%), rising to 94.2% (92.0% to 96.0%) for hypoplastic left heart syndrome (HLHS). There were 1766 terminations (15.7%, 95% CI 14.7% to 16.7%), 295 fetal losses (2.6%, 95% CI 1.6% to 3.6%), 4538 live births with no infant cardiac intervention (40.3%, 95% CI 39.3% to 41.3%) and 4666 with intervention(s) (41.4%, 95% CI 40.4% to 42.4%). Termination was higher with greater CHD complexity (eg, HLHS 51.1% (95% CI 46.8% to 55.5%) versus isolated ventricular septal defect 6.0% (95% CI 4.3% to 7.7%), p<0.001), non-cardiac comorbidities (23.6% (95% CI 21.9% to 25.4%) vs 11.3% (95% CI 10.1% to 12.6%), p<0.001), and least versus most deprived areas (20.3% (95% CI 17.5% to 23.1%) vs 11.6% (95% CI 9.7% to 13.5%), p<0.001). Infant mortality was 13.3% (602/4538) in the no-intervention group and 5.2% (243/4666) in the intervention group; those deaths without intervention (n=602) were predominantly cases with critical CHD (n=154), preterm birth (n=301) and/or comorbidity (n=362).
conclusionThis national, linked cohort shows that un-intervened cases account for most infant deaths and that antenatal detection exceeds 90% for the most complex lesions. Registries and quality improvement should include all CHD care pathways to inform counselling and equitable service planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.